Patrick Soon-Shiong is a physician, surgeon, scientist and a pioneer in his field. Dr. Soon-Shiong is the founder of the project NantWorks. As of 2015, he is the chairman and chief executive officer of NantKwest, a clinical stage immunotherapy company.
Born to Chinese immigrants to South Africa, Patrick Soon-Shiong became a doctor at the age of 23. Dr. Soon-Shiong has acquired global acclaim for his pioneering works, particularly in the therapy of cancer and diabetes. He invented and developed the cancer drug Abraxane, which is an FDA-approved treatment for metastatic breast cancer, lung cancer and pancreatic cancer. The project NantWorks aims to integrate and enable sharing of patient information on a global level.